In the study of Gütgemann et al. (30), 98 samples of bile duct tumors were examined for CD56 expression by IHC staining, and they found positive in 4 samples out of 32 cholangiocarcinoma (12.5%). This evidence concerns the gene NCAM1 and bile duct neoplasm.